Skip to main content
Erschienen in: Reactions Weekly 1/2016

01.11.2016 | Case report

Docetaxel

Neutropenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Nosov A, et al. Neoadjuvant Chemotherapy Using Reduced-Dose Docetaxel Followed by Radical Prostatectomy for Patients With Intermediate and High-Risk Prostate Cancer: A Single-Center Study. Prostate 76: 1345-1352, No. 15, Nov 2016. Available from: URL: http://doi.org/10.1002/pros.23165 - RussiaCrossRefPubMed Nosov A, et al. Neoadjuvant Chemotherapy Using Reduced-Dose Docetaxel Followed by Radical Prostatectomy for Patients With Intermediate and High-Risk Prostate Cancer: A Single-Center Study. Prostate 76: 1345-1352, No. 15, Nov 2016. Available from: URL: http://​doi.​org/​10.​1002/​pros.​23165 - RussiaCrossRefPubMed
Metadaten
Titel
Docetaxel
Neutropenia: case report
Publikationsdatum
01.11.2016
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-016-22800-z

Weitere Artikel der Ausgabe 1/2016

Reactions Weekly 1/2016 Zur Ausgabe

Case report

AZD4547

Case report

Clozapine